Literature DB >> 20160496

p53-mediated induction of Noxa and p53AIP1 requires NFkappaB.

Jim O'Prey1, Diane Crighton, Angel G Martin, Karen H Vousden, Howard O Fearnhead, Kevin M Ryan.   

Abstract

The intricate regulation of cell survival and cell death is critical for the existence of both normal and transformed cells. Two factors central to these processes are p53 and NFkappaB, with both factors having ascribed roles in both promoting and repressing cell death. Not surprisingly, a number of studies have previously reported interplay between p53 and NFkappaB. The mechanistic basis behind these observations, however, is currently incomplete. We report here further insights into this interplay using a system where blockade of NFkappaB inhibits cell death from p53, but at the same time sensitizes cells to death by TNFalpha. We found in agreement with a recent report showing that NFkappaB is required for the efficient activation of the BH3-only protein Noxa by the p53 family member p73, that p53's ability to induce Noxa is also impeded by inhibition of NFkappaB. In contrast to the regulation by p73, however, blockade of NFkappaB downstream of p53 decreases Noxa protein levels without effects on Noxa mRNA. Our further analysis of the effects of NFkappaB inhibition on p53 target gene expression revealed that while most target genes analysed where unaffected by blockade of NFkappaB, the p53-mediated induction of the pro-apoptotic gene p53AIP1 was significantly dependent on NFkappaB. These studies therefore add further insight into the complex relationship of p53 and NFkappaB. In addition, since both Noxa and p53AIP1 have been shown to be important components of p53-mediated cell death responses, these findings may also indicate critical points where NFkappaB plays a pro-apoptotic role downstream of p53.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20160496     DOI: 10.4161/cc.9.5.10872

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  23 in total

1.  p53 protects against LPS-induced lung endothelial barrier dysfunction.

Authors:  Nektarios Barabutis; Christiana Dimitropoulou; Charalampos Birmpas; Atul Joshi; Gagan Thangjam; John D Catravas
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-02-20       Impact factor: 5.464

2.  Trans-Cinnamaldehyde, An Essential Oil in Cinnamon Powder, Ameliorates Cerebral Ischemia-Induced Brain Injury via Inhibition of Neuroinflammation Through Attenuation of iNOS, COX-2 Expression and NFκ-B Signaling Pathway.

Authors:  Yuh-Fung Chen; Yu-Wen Wang; Wei-Shih Huang; Ming-Ming Lee; W Gibson Wood; Yuk-Man Leung; Huei-Yann Tsai
Journal:  Neuromolecular Med       Date:  2016-04-18       Impact factor: 3.843

3.  A novel mechanism of crosstalk between the p53 and NFκB pathways: MDM2 binds and inhibits p65RelA.

Authors:  Kristina Heyne; Christine Winter; Fabian Gerten; Christina Schmidt; Klaus Roemer
Journal:  Cell Cycle       Date:  2013-06-28       Impact factor: 4.534

4.  Effects of tyrosine kinase inhibitor E7080 and eNOS inhibitor L-NIO on colorectal cancer alone and in combination.

Authors:  Ahmet Altun; Tijen Kaya Temiz; Ezgi Balcı; Zübeyde Akın Polat; Mustafa Turan
Journal:  Chin J Cancer Res       Date:  2013-10       Impact factor: 5.087

5.  Tumor protein p63/nuclear factor κB feedback loop in regulation of cell death.

Authors:  Tanusree Sen; Nilkantha Sen; Yiping Huang; Debasish Sinha; Zhen-Ge Luo; Edward A Ratovitski; David Sidransky
Journal:  J Biol Chem       Date:  2011-10-20       Impact factor: 5.157

6.  Inflammation and p53: A Tale of Two Stresses.

Authors:  Andrei V Gudkov; Katerina V Gurova; Elena A Komarova
Journal:  Genes Cancer       Date:  2011-04

7.  Apoptosis induced by mammalian reovirus is beta interferon (IFN) independent and enhanced by IFN regulatory factor 3- and NF-κB-dependent expression of Noxa.

Authors:  Jonathan J Knowlton; Terence S Dermody; Geoffrey H Holm
Journal:  J Virol       Date:  2011-11-16       Impact factor: 5.103

8.  cIAP2 represses IKKα/β-mediated activation of MDM2 to prevent p53 degradation.

Authors:  Rosanna Lau; Min Ying Niu; M A Christine Pratt
Journal:  Cell Cycle       Date:  2012-10-03       Impact factor: 4.534

Review 9.  p53 and the Carcinogenicity of Chronic Inflammation.

Authors:  Andrei V Gudkov; Elena A Komarova
Journal:  Cold Spring Harb Perspect Med       Date:  2016-11-01       Impact factor: 6.915

10.  Repeated stimulation by LPS promotes the senescence of DPSCs via TLR4/MyD88-NF-κB-p53/p21 signaling.

Authors:  Guijuan Feng; Ke Zheng; Tong Cao; Jinlong Zhang; Min Lian; Dan Huang; Changbo Wei; Zhifeng Gu; Xingmei Feng
Journal:  Cytotechnology       Date:  2018-02-26       Impact factor: 2.058

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.